$4.47
-0.23-4.89%
Pre-Market: 4:32 PM EDT
15 minutes delayed
MaxCyte
MXCTNASDAQ
Latest news for MaxCyte (NASDAQ:MXCT) Stock
MaxCyte Stock (NASDAQ: MXCT)
Categories: All
Wednesday, May 22, 2024
Wednesday, May 08, 2024
- Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- MaxCyte shares are trading higher after the c...
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
Tuesday, May 07, 2024
Tuesday, April 23, 2024
Tuesday, April 02, 2024
Wednesday, March 20, 2024
Wednesday, March 13, 2024
- Stephens & Co. Reiterates Overweight on MaxCy...
- NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
- BTIG Maintains Buy on MaxCyte, Lowers Price T...
- MaxCyte shares are trading higher after the c...
- Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Tuesday, March 12, 2024
Monday, March 11, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
Tuesday, January 30, 2024
Tuesday, January 23, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
Wednesday, January 03, 2024
Tuesday, January 02, 2024
Monday, December 11, 2023
Wednesday, December 06, 2023
Wednesday, November 29, 2023
Wednesday, November 08, 2023
Thursday, October 05, 2023
- Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline
- Crude Oil Down 2%; ConAgra Brands Earnings Top Views
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Thursday
- Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- MaxCyte shares are trading lower after the co...
- Stephens & Co. Reiterates Overweight on MaxCy...
- Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket